Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review
- PMID: 31480656
- PMCID: PMC6769995
- DOI: 10.3390/nu11092048
Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review
Abstract
Irritable bowel syndrome (IBS) is a frequent functional gastrointestinal disorder, and alterations in the gut microbiota composition contributes to symptom generation. The exact mechanisms of probiotics in the human body are not fully understood, but probiotic supplements are thought to improve IBS symptoms through manipulation of the gut microbiota. The aim of this systematic review was to assess the latest randomized controlled trials (RCTs) evaluating the effect of probiotic supplementation on symptoms in IBS patients. A literature search was conducted in Medline (PubMed) until March 2019. RCTs published within the last five years evaluating effects of probiotic supplements on IBS symptoms were eligible. The search identified in total 35 studies, of which 11 met the inclusion criteria and were included in the systematic review. Seven studies (63.6%) reported that supplementation with probiotics in IBS patients significantly improved symptoms compared to placebo, whereas the remaining four studies (36.4%) did not report any significant improvement in symptoms after probiotic supplementation. Of note, three studies evaluated the effect of a mono-strain supplement, whereas the remaining eight trials used a multi-strain probiotic. Overall, the beneficial effects were more distinct in the trials using multi-strain supplements with an intervention of 8 weeks or more, suggesting that multi-strain probiotics supplemented over a period of time have the potential to improve IBS symptoms.
Keywords: gut microbiota; irritable bowel syndrome; probiotics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Effectiveness of Probiotic Use in Alleviating Symptoms of Irritable Bowel Syndrome: A Systematic Review.Cureus. 2024 Apr 15;16(4):e58306. doi: 10.7759/cureus.58306. eCollection 2024 Apr. Cureus. 2024. PMID: 38752062 Free PMC article. Review.
-
Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis.Sultan Qaboos Univ Med J. 2020 Feb;20(1):e13-e24. doi: 10.18295/squmj.2020.20.01.003. Epub 2020 Mar 9. Sultan Qaboos Univ Med J. 2020. PMID: 32190365 Free PMC article.
-
A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.BMC Gastroenterol. 2018 May 25;18(1):71. doi: 10.1186/s12876-018-0788-9. BMC Gastroenterol. 2018. PMID: 29801486 Free PMC article. Clinical Trial.
-
British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).J Hum Nutr Diet. 2016 Oct;29(5):576-92. doi: 10.1111/jhn.12386. Epub 2016 Jun 6. J Hum Nutr Diet. 2016. PMID: 27265510 Review.
-
Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.World J Gastroenterol. 2015 Mar 14;21(10):3072-84. doi: 10.3748/wjg.v21.i10.3072. World J Gastroenterol. 2015. PMID: 25780308 Free PMC article. Review.
Cited by
-
Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients-A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial.Nutrients. 2024 May 16;16(10):1503. doi: 10.3390/nu16101503. Nutrients. 2024. PMID: 38794741 Free PMC article. Clinical Trial.
-
Effectiveness of Probiotic Use in Alleviating Symptoms of Irritable Bowel Syndrome: A Systematic Review.Cureus. 2024 Apr 15;16(4):e58306. doi: 10.7759/cureus.58306. eCollection 2024 Apr. Cureus. 2024. PMID: 38752062 Free PMC article. Review.
-
Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies.J Neuroinflammation. 2024 May 10;21(1):124. doi: 10.1186/s12974-024-03118-3. J Neuroinflammation. 2024. PMID: 38730498 Free PMC article. Review.
-
The role of Weizmannia (Bacillus) coagulans LMG S-31876 in treating IBS-diarrhea.Front Nutr. 2024 Feb 5;10:1310462. doi: 10.3389/fnut.2023.1310462. eCollection 2023. Front Nutr. 2024. PMID: 38375355 Free PMC article.
-
Comparison of the efficacy of fish oil and probiotic supplementation on glucose and lipid metabolism in patients with type 2 diabetes: a systematic review and network meta-analysis.Diabetol Metab Syndr. 2024 Jan 22;16(1):25. doi: 10.1186/s13098-024-01266-3. Diabetol Metab Syndr. 2024. PMID: 38254166 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous